Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.93 CHF -4.08% Market Closed
Market Cap: 368.5m CHF

Medmix Ltd
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medmix Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Medmix Ltd
SIX:MEDX
EPS (Diluted)
CHf0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
EPS (Diluted)
CHf151
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
-3%
Sonova Holding AG
SIX:SOON
EPS (Diluted)
CHf9
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
6%
Medacta Group SA
SIX:MOVE
EPS (Diluted)
€2
CAGR 3-Years
9%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Straumann Holding AG
SIX:STMN
EPS (Diluted)
CHf2
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
N/A

Medmix Ltd
Glance View

Market Cap
364.3m CHF
Industry
Health Care

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

MEDX Intrinsic Value
13.85 CHF
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Medmix Ltd's EPS (Diluted)?
EPS (Diluted)
-0.2 CHF

Based on the financial report for Dec 31, 2024, Medmix Ltd's EPS (Diluted) amounts to -0.2 CHF.

Back to Top